Figure 1
From: Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma
Expression of EZH2 in three liver cancer cell lines (Hep3B, HepG2 and HuH7). M: marker; P: positive control (Human Universal Reference total RNA, Clontech, Palo Alto, CA, USA); N: negative control (distilled water); GAPDH: glyceraldehyde-3-phosphate dehydrogenase.
